Thrombotic Long-Term Consequences of SARS-CoV-2 Infection in Patients with Compensated Cirrhosis: A Propensity Score-Matched Analysis of a U.S. Database.

Mark AyoubCarol FarisTajana JuranovicRafi AibaniMorgan KoontzHarleen ChelaNadeem AnwarEbubekir Daglilar

Published in: Diseases (Basel, Switzerland) (2024)

The presence of SARS-CoV-2 infection in patients with compensated cirrhosis was associated with a higher rate of PVT, DVT, and PE at 6 months, and 1 and 3 years.

Keyphrases

respiratory syndrome coronavirus
sars cov
adverse drug
coronavirus disease
electronic health record